• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疑似转甲状腺素蛋白心脏淀粉样变性患者的Tc-焦磷酸盐闪烁扫描术的平面侧位成像

Lateral Planar Imaging of Tc-pyrophosphate Scintigraphy in Patients with Suspected Transthyretin Cardiac Amyloidosis.

作者信息

Saitou Toshinori, Aikawa Tadao, Manabe Osamu, Fujimoto Shinichiro, Matsue Yuya, Nagase Atsushi, Toyama Hiroaki, Kudo Tamaki, Oyama-Manabe Noriko, Minamino Tohru

机构信息

Department of Radiology, Hokkaido Cardiovascular Hospital, Hokkaido, Japan.

Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

出版信息

Ann Nucl Cardiol. 2024;10(1):29-37. doi: 10.17996/anc.24-00002. Epub 2024 Oct 31.

DOI:10.17996/anc.24-00002
PMID:39635323
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11612391/
Abstract

: Lateral planar Tc-pyrophosphate (PYP) imaging is recommended as a standardized acquisition method because it helps separate extracardiac uptake from the myocardium. We evaluated its discriminatory performance in detecting myocardial PYP uptake, using single-photon emission computed tomography (SPECT) as a reference standard. : We retrospectively evaluated 170 patients who underwent PYP imaging for suspected transthyretin cardiac amyloidosis. Anterior and lateral planar imaging and SPECT were performed 3 h after PYP administration. The myocardial PYP uptake on planar and SPECT images was visually assessed and quantified using the heart-to-contralateral lung uptake (H/CL) ratio. The heart-to-mediastinum uptake (H/M) ratio was calculated as the mean count of the region of interest in the heart divided by that in the superior mediastinum on lateral planar images. : Patients with PYP SPECT-positive results had significantly higher H/M ratios at 3 h than those with PYP SPECT-negative results (1.23 [interquartile range: IQR, 1.15-1.43] vs. 1.08 [IQR, 1.02-1.16]; <0.001). A reclassification analysis that added the H/M ratio to visual scores for detecting positive PYP SPECT yielded a significant improvement with a net reclassification improvement (NRI) of 0.56 (95%CI, 0.25-0.87; <0.001) and integrated discrimination improvement (IDI) of 0.038 (95%CI, 0.005-0.072; =0.026). The H/M ratio significantly improved the predictive ability of SPECT findings based on the visual scores and H/CL ratio with an NRI of 0.49 (95%CI, 0.18-0.81; =0.003) and IDI of 0.036 (95%CI, 0.004-0.069; =0.029). : Adding the H/M ratio derived from lateral planar PYP imaging to visual scores or the H/CL ratio on anterior planar images improved the accuracy of detecting significant myocardial uptake on SPECT.

摘要

推荐采用平面侧位锝焦磷酸盐(PYP)显像作为标准化采集方法,因为它有助于区分心肌摄取与心外摄取。我们以单光子发射计算机断层扫描(SPECT)作为参考标准,评估了其在检测心肌PYP摄取方面的鉴别性能。

我们回顾性评估了170例因疑似转甲状腺素蛋白心脏淀粉样变性而接受PYP显像的患者。在注射PYP后3小时进行前位和平面侧位显像以及SPECT检查。通过心脏与对侧肺摄取(H/CL)比值对平面和SPECT图像上的心肌PYP摄取进行视觉评估和定量分析。心脏与纵隔摄取(H/M)比值计算为平面侧位图像上心感兴趣区的平均计数除以上纵隔感兴趣区的平均计数。

PYP SPECT检查结果为阳性的患者在3小时时的H/M比值显著高于PYP SPECT检查结果为阴性的患者(1.23[四分位间距:IQR,1.15 - 1.43] 对比 1.08[IQR,1.02 - 1.16];P<0.001)。将H/M比值添加到用于检测PYP SPECT阳性的视觉评分中的重新分类分析显示有显著改善,净重新分类改善(NRI)为0.56(95%CI,0.25 - 0.87;P<0.001),综合鉴别改善(IDI)为0.038(95%CI,0.005 - 0.072;P = 0.026)。基于视觉评分和H/CL比值,H/M比值显著提高了SPECT检查结果的预测能力,NRI为0.49(95%CI,0.18 - 0.81;P = 0.003),IDI为0.036(95%CI,0.004 - 0.069;P = 0.029)。

将平面侧位PYP显像得出的H/M比值添加到视觉评分或前位平面图像的H/CL比值中,可提高检测SPECT上显著心肌摄取的准确性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0042/11612391/ef2a25f2938e/anc-10-29-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0042/11612391/945a78ec63b5/anc-10-29-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0042/11612391/bab3074982db/anc-10-29-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0042/11612391/ef2a25f2938e/anc-10-29-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0042/11612391/945a78ec63b5/anc-10-29-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0042/11612391/bab3074982db/anc-10-29-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0042/11612391/ef2a25f2938e/anc-10-29-g003.jpg

相似文献

1
Lateral Planar Imaging of Tc-pyrophosphate Scintigraphy in Patients with Suspected Transthyretin Cardiac Amyloidosis.疑似转甲状腺素蛋白心脏淀粉样变性患者的Tc-焦磷酸盐闪烁扫描术的平面侧位成像
Ann Nucl Cardiol. 2024;10(1):29-37. doi: 10.17996/anc.24-00002. Epub 2024 Oct 31.
2
Comparison of 1-h with 3-h planar Tc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard.用 SPECT 作为参考标准比较 1 小时与 3 小时平面 Tc-焦磷酸盐闪烁显像在疑似转甲状腺素蛋白心脏淀粉样变性患者中的应用。
Ann Nucl Med. 2023 Feb;37(2):99-107. doi: 10.1007/s12149-022-01807-8. Epub 2022 Nov 10.
3
A Quantitative Diagnostic Method Using Tc-pyrophosphate Lateral Planar Images to Distinguish Between Transthyretin Amyloid Cardiomyopathy and False-Positive Images Due to Blood Pools.一种使用锝-焦磷酸盐侧位平面图像区分转甲状腺素蛋白淀粉样心肌病和血池导致的假阳性图像的定量诊断方法。
Ann Nucl Cardiol. 2024;10(1):23-28. doi: 10.17996/anc.24-00001. Epub 2024 Oct 31.
4
Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.疑似心脏淀粉样变性患者的锝-99m焦磷酸钠/铊-201双同位素同时心肌单光子发射计算机断层显像
J Nucl Cardiol. 2020 Feb;27(1):28-37. doi: 10.1007/s12350-019-01753-5. Epub 2019 Jun 6.
5
Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.多中心研究 99mTc 焦磷酸盐平面心肌显像术:预测ATTR 心脏淀粉样变性患者的生存率。
JAMA Cardiol. 2016 Nov 1;1(8):880-889. doi: 10.1001/jamacardio.2016.2839.
6
Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.平面与断层焦磷酸盐闪烁显像术在转甲状腺素蛋白心脏淀粉样变性中的比较:风险与陷阱。
J Nucl Cardiol. 2021 Feb;28(1):104-111. doi: 10.1007/s12350-020-02328-5. Epub 2020 Sep 8.
7
A case report of an uncommon presentation of technetium pyrophosphate scintigraphy in transthyretin cardiac amyloidosis: A potential diagnostic pitfall, pseudo-positive or pseudo-negative?转甲状腺素蛋白心脏淀粉样变性中焦磷酸锝闪烁显像罕见表现的病例报告:潜在的诊断陷阱、假阳性还是假阴性?
J Cardiol Cases. 2019 Oct 8;21(2):50-53. doi: 10.1016/j.jccase.2019.09.013. eCollection 2020 Feb.
8
Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution.锝 99m 焦磷酸盐诊断转甲状腺素心脏淀粉样变性:一项不断发展的试验。
JACC Cardiovasc Imaging. 2021 Jun;14(6):1221-1231. doi: 10.1016/j.jcmg.2020.08.027. Epub 2020 Nov 18.
9
Global and Regional Reduction of Myocardial Perfusion in Patients with Transthyretin Type of Cardiac Amyloidosis: A Dual SPECT Study Using Tc Pyrophosphate and Thallium.转甲状腺素蛋白型心脏淀粉样变性患者心肌灌注的全球和区域减少:一项使用锝焦磷酸盐和铊的双SPECT研究
Ann Nucl Cardiol. 2024;10(1):16-22. doi: 10.17996/anc.23-00009. Epub 2024 Oct 31.
10
Imaging of cardiac amyloidosis by (99m)Tc-PYP scintigraphy.用(99m)锝-焦磷酸显像对心脏淀粉样变性进行成像。
Hell J Nucl Med. 2015 Sep-Dec;18 Suppl 1:42-50.

引用本文的文献

1
Advances in imaging-based diagnosis, prognosis, and response assessment in cardiac amyloidosis: a comprehensive multimodality review.心脏淀粉样变性基于成像的诊断、预后及反应评估进展:一项综合性多模态综述
Ann Nucl Med. 2025 Aug 25. doi: 10.1007/s12149-025-02092-x.
2
Cardiac Amyloidosis, Should We See It from the Side or the Front?心脏淀粉样变性,我们应该从侧面还是正面看待它?
Ann Nucl Cardiol. 2024;10(1):4-5. doi: 10.17996/anc.24-00004. Epub 2024 Oct 31.

本文引用的文献

1
Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc pyrophosphate (PYP) imaging for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP study.Tc 焦磷酸盐(PYP)平面定量和半定量参数成像诊断转甲状腺素蛋白(ATTR)心脏淀粉样变的诊断性能特征:SCAN-MP 研究。
J Nucl Cardiol. 2023 Aug;30(4):1414-1419. doi: 10.1007/s12350-023-03203-9. Epub 2023 Feb 23.
2
Diagnostic value of heart-to-mediastinum ratio in Tc-pyrophospate SPECT/CT for transthyretin cardiac amyloidosis.心肌与纵隔比在 Tc-焦磷酸盐 SPECT/CT 诊断转甲状腺素蛋白心脏淀粉样变性中的价值。
J Nucl Cardiol. 2023 Aug;30(4):1374-1381. doi: 10.1007/s12350-022-03180-5. Epub 2022 Dec 22.
3
Comparison of 1-h with 3-h planar Tc-pyrophosphate scintigraphy in patients with suspected transthyretin cardiac amyloidosis using SPECT as a reference standard.
用 SPECT 作为参考标准比较 1 小时与 3 小时平面 Tc-焦磷酸盐闪烁显像在疑似转甲状腺素蛋白心脏淀粉样变性患者中的应用。
Ann Nucl Med. 2023 Feb;37(2):99-107. doi: 10.1007/s12149-022-01807-8. Epub 2022 Nov 10.
4
Volumetric evaluation of Tc-pyrophosphate SPECT/CT for transthyretin cardiac amyloidosis: Methodology and correlation with cardiac functional parameters.Tc-焦磷酸盐 SPECT/CT 对转甲状腺素蛋白心脏淀粉样变性的容积评估:方法学及与心脏功能参数的相关性。
J Nucl Cardiol. 2022 Dec;29(6):3102-3110. doi: 10.1007/s12350-021-02857-7. Epub 2021 Dec 14.
5
Impaired left ventricular global longitudinal strain is associated with elevated left ventricular filling pressure after myocardial infarction.心肌梗死后左心室整体纵向应变受损与左心室充盈压升高有关。
Am J Physiol Heart Circ Physiol. 2020 Dec 1;319(6):H1474-H1481. doi: 10.1152/ajpheart.00502.2020. Epub 2020 Oct 9.
6
Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.平面与断层焦磷酸盐闪烁显像术在转甲状腺素蛋白心脏淀粉样变性中的比较:风险与陷阱。
J Nucl Cardiol. 2021 Feb;28(1):104-111. doi: 10.1007/s12350-020-02328-5. Epub 2020 Sep 8.
7
A case report of an uncommon presentation of technetium pyrophosphate scintigraphy in transthyretin cardiac amyloidosis: A potential diagnostic pitfall, pseudo-positive or pseudo-negative?转甲状腺素蛋白心脏淀粉样变性中焦磷酸锝闪烁显像罕见表现的病例报告:潜在的诊断陷阱、假阳性还是假阴性?
J Cardiol Cases. 2019 Oct 8;21(2):50-53. doi: 10.1016/j.jccase.2019.09.013. eCollection 2020 Feb.
8
ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.美国核医学与分子影像学会/美国心脏协会/美国超声心动图学会/欧洲核医学协会/美国心力衰竭学会/美国心律学会/心血管磁共振学会/美国核医学与分子影像学会关于心脏淀粉样变性多模态成像的专家共识建议:第1部分——证据基础和标准化成像方法
J Nucl Cardiol. 2019 Dec;26(6):2065-2123. doi: 10.1007/s12350-019-01760-6.
9
Combination of Commonly Examined Parameters Is a Useful Predictor of Positive Tc-Labeled Pyrophosphate Scintigraphy Findings in Elderly Patients With Suspected Transthyretin Cardiac Amyloidosis.联合常规检查参数是预测老年疑似转甲状腺素蛋白心脏淀粉样变患者 Tc 标记焦磷酸盐闪烁显像阳性的有用指标。
Circ J. 2019 Jul 25;83(8):1698-1708. doi: 10.1253/circj.CJ-19-0255. Epub 2019 Jun 13.
10
Treatment of cardiac transthyretin amyloidosis: an update.心脏转甲状腺素淀粉样变性的治疗:最新进展。
Eur Heart J. 2019 Dec 1;40(45):3699-3706. doi: 10.1093/eurheartj/ehz298.